← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksHQYPrice Target
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

HQY logoHealthEquity, Inc. (HQY) Price Target Analysis

Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026

Current Price
$83.99
Market reference
Price Target
$109.89
+30.8% Upside
Target Range
$89.00 — $125.00
Moderate consensus
Analyst Rating
Buy
27 analysts
Forward P/E21.2x
Trailing P/E34.1x
Forward PEG0.26
Implied Growth+60.8%
Median Target$110.00
Analyst Spread32.8%

Analysts see +30.8% upside to their consensus target of $109.89. The bullish rating consensus aligns with positive price target gap.

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$83.99
Consensus$109.89
High$125.00
Low$89.00
Bear Case
$89
+6.0%
Consensus
$110
+30.8%
Bull Case
$125
+48.8%

Analyst Ratings Distribution

Breakdown of 27 published analyst recommendations for HQY

25/27 analysts are bullish
+46
BearishBullish
Weighted analyst sentiment score based on 27 ratings
ConsensusBuy
Coverage27 Analysts
Net Score+46
Bull / Bear93% / 4%
Strong Buy14%
Buy2489%
Hold14%
Sell14%
Strong Sell00%
Strong Buy
14%
Buy
2489%
Hold
14%
Sell
14%
Strong Sell
00%
Recommendation Mix93% Buy · 4% Hold · 4% Sell
Buy (25)Hold (1)Sell (1)

HQY Price Target Analysis

Updated May 8, 2026

As of May 8, 2026, HealthEquity, Inc. (HQY) has a Wall Street consensus price target of $109.89, based on estimates from 27 covering analysts. With the stock currently trading at $83.99, this represents a potential upside of +30.8%. The company has a market capitalization of $7.14B.

Analyst price targets range from a low of $89.00 to a high of $125.00, representing a 33% spread in expectations. The median target of $110.00 aligns closely with the consensus average.

The current analyst consensus rating is Buy, with 25 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, HQY trades at a trailing P/E of 34.1x and forward P/E of 21.2x. The forward PEG ratio of 0.26 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +60.8% over the next year.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside+26.9%
Avg Forward P/E16.6x
Peers with Coverage10 / 10
CompanyMarket CapPriceTargetUpsideRatingFwd P/EAnalysts
WEX logoWEXWEX Inc.$5.0B$144.26$177.67+23.2%Hold7.4x32
BEN logoBENFranklin Resources, Inc.$15.9B$30.52$28.75-5.8%Hold11.2x27
INVA logoINVAInnoviva, Inc.$1.9B$22.80$37.67+65.2%Buy11.9x10
GWRE logoGWREGuidewire Software, Inc.$11.8B$139.58$245.17+75.6%Buy39.7x26
PCTY logoPCTYPaylocity Holding Corporation$5.9B$109.12$168.08+54.0%Buy14.0x41
PAYC logoPAYCPaycom Software, Inc.$7.5B$138.43$149.36+7.9%Hold13.2x36
ADP logoADPAutomatic Data Processing, Inc.$86.2B$214.09$249.00+16.3%Hold19.4x36
PAYX logoPAYXPaychex, Inc.$33.8B$94.26$112.14+19.0%Hold17.2x30
UNH logoUNHUnitedHealth Group Incorporated$335.6B$369.74$385.43+4.2%Buy20.2x52
CVS logoCVSCVS Health Corporation$111.4B$87.31$95.20+9.0%Buy12.2x41

Upside Potential Comparison

GWRE logoGWRE
+75.6%
INVA logoINVA
+65.2%
PCTY logoPCTY
+54.0%
WEX logoWEX
+23.2%
PAYX logoPAYX
+19.0%
ADP logoADP
+16.3%
CVS logoCVS
+9.0%
PAYC logoPAYC
+7.9%

See HQY's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is HQY Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare HQY vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

HQY — Frequently Asked Questions

Quick answers to the most common questions about buying HQY stock.

What is the HQY stock price target for 2026?

The consensus Wall Street price target for HQY is $109.89, representing 30.8% upside from the current price of $83.99. With 27 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is HQY a buy, sell, or hold?

HQY has a consensus rating of "Buy" based on 27 Wall Street analysts. The rating breakdown is predominantly bullish, with 25 Buy/Strong Buy ratings. The consensus 12-month price target of $109.89 implies 30.8% upside from current levels.

Is HQY stock overvalued or undervalued?

HQY trades at a forward P/E of 21.2316x, representing a moderate valuation. With analysts targeting $109.89 (30.8% implied move), the stock appears reasonably valued with upside.

How high can HQY stock go?

The most bullish Wall Street analyst has a price target of $125 for HQY, while the most conservative target is $89. The consensus of $109.89 represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover HQY stock?

HQY is heavily covered by Wall Street, with 27 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 24 have Buy ratings, 1 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the HQY stock forecast?

The 12-month HQY stock forecast based on 27 Wall Street analysts shows a consensus price target of $109.89, with estimates ranging from $89 (bear case) to $125 (bull case). The median consensus rating is "Buy".

What is HQY's forward P/E ratio?

HQY trades at a forward P/E ratio of 21.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 34.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy HQY stock?

Wall Street analysts are very optimistic on HQY, with a "Buy" consensus rating and $109.89 price target (30.8% upside). 25 of 27 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do HQY price targets vary so much?

HQY analyst price targets range from $89 to $125, a 33% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $109.89 consensus represents the middle ground.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.